Shares of IMS Health Holdings Inc. (NYSE:IMS) saw strong trading volume on Friday . 2,338,174 shares traded hands during trading, an increase of 59% from the previous session’s volume of 1,468,886 shares.The stock last traded at $27.68 and had previously closed at $26.78.

A number of research analysts have commented on the stock. Wells Fargo & Co. cut shares of IMS Health Holdings from an “outperform” rating to a “market perform” rating in a research report on Thursday, May 12th. Zacks Investment Research cut shares of IMS Health Holdings from a “buy” rating to a “hold” rating in a research report on Thursday, May 5th. Topeka Capital Markets increased their price target on shares of IMS Health Holdings from $29.00 to $30.00 and gave the company a “buy” rating in a research report on Wednesday, May 4th. Finally, Piper Jaffray Cos. reiterated an “overweight” rating and set a $32.00 price target (up from $28.00) on shares of IMS Health Holdings in a research report on Thursday, March 24th. Three analysts have rated the stock with a hold rating and six have issued a buy rating to the company. IMS Health Holdings presently has a consensus rating of “Buy” and a consensus price target of $31.22.

The firm’s 50 day moving average is $25.50 and its 200-day moving average is $25.31. The company has a market cap of $9.13 billion and a price-to-earnings ratio of 56.84.

IMS Health Holdings (NYSE:IMS) last posted its quarterly earnings results on Tuesday, May 3rd. The company reported $0.42 EPS for the quarter, topping the Zacks’ consensus estimate of $0.38 by $0.04. The business earned $774 million during the quarter, compared to analysts’ expectations of $749.34 million. The firm’s revenue for the quarter was up 22.5% on a year-over-year basis. During the same period in the prior year, the firm posted $0.39 earnings per share. On average, equities analysts expect that IMS Health Holdings Inc. will post $1.60 EPS for the current year.

A number of hedge funds and institutional investors have bought and sold shares of the company. Korea Investment CORP acquired a new position in IMS Health Holdings during the fourth quarter worth approximately $1,077,000. Calamos Advisors LLC boosted its stake in shares of IMS Health Holdings by 25.8% in the fourth quarter. Calamos Advisors LLC now owns 1,386,910 shares of the company’s stock valued at $35,325,000 after buying an additional 284,857 shares during the period. Oxford Asset Management purchased a new stake in shares of IMS Health Holdings during the fourth quarter valued at about $1,574,000. Stevens Capital Management LP boosted its stake in shares of IMS Health Holdings by 44.5% in the fourth quarter. Stevens Capital Management LP now owns 82,102 shares of the company’s stock valued at $2,091,000 after buying an additional 25,277 shares during the period. Finally, Great West Life Assurance Co. Can boosted its stake in shares of IMS Health Holdings by 85.4% in the fourth quarter. Great West Life Assurance Co. Can now owns 76,933 shares of the company’s stock valued at $1,959,000 after buying an additional 35,431 shares during the period.

IMS Health Holdings, Inc (IMS) is an information and technology services company that provides solutions to its clients in the healthcare industry. The Company has its presence in over 100 countries. The Company’s data set contains over 10 petabytes of data and over 500 million patient records. It serves healthcare organizations and life science companies, including pharmaceutical, biotechnology, consumer health and medical device manufacturers, as well as distributors, providers, payers, government agencies, policymakers, researchers and the financial community.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.